Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination.

Area of Science:

• Medical research and biotechnology
• Infectious disease therapeutics
• Genomic medicine

Background:

• Global health organizations prioritize developing new medicines for infectious diseases, especially chronic or emerging ones.
• Current treatments face challenges in effectiveness, safety, and accessibility.
• Genetic technologies present novel therapeutic design possibilities.

Purpose of the Study:

• To review recent advances in genetic technologies for infectious disease treatment.
• To highlight cross-disciplinary applications, such as with oncology.
• To address logistical and economic factors for global accessibility.

Main Methods:

• Review of current scientific literature on genetic technologies in infectious diseases.
• Analysis of emerging therapeutic modalities like mRNA vaccines, CRISPR, and immunotherapies.
• Examination of translational challenges and economic considerations.

Main Results:

• Genetic technologies, including mRNA vaccines and CRISPR gene editing, show significant promise for infectious disease control.
• Cross-field fertilization, particularly with oncology, is driving innovation.
• Logistical and economic hurdles must be overcome for widespread access.

Conclusions:

• Advances in genetic technologies offer powerful new tools for combating infectious diseases.
• Interdisciplinary collaboration and addressing accessibility are crucial for realizing the full potential of these therapies.
• Future efforts should focus on equitable global distribution of these innovative treatments.